| Title |
Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain
|
|---|---|
| Published in |
Drugs, May 2019
|
| DOI | 10.1007/s40265-019-01132-x |
| Pubmed ID | |
| Authors |
Henry L. Blanton, Jennifer Brelsfoard, Nathan DeTurk, Kevin Pruitt, Madhusudhanan Narasimhan, Daniel J. Morgan, Josée Guindon |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 17% |
| Spain | 1 | 17% |
| New Zealand | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Science communicators (journalists, bloggers, editors) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 195 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 195 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 55 | 28% |
| Researcher | 21 | 11% |
| Student > Master | 18 | 9% |
| Student > Bachelor | 16 | 8% |
| Other | 10 | 5% |
| Other | 24 | 12% |
| Unknown | 51 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Neuroscience | 55 | 28% |
| Medicine and Dentistry | 35 | 18% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 7% |
| Nursing and Health Professions | 7 | 4% |
| Biochemistry, Genetics and Molecular Biology | 6 | 3% |
| Other | 24 | 12% |
| Unknown | 55 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2019.
All research outputs
#7,735,018
of 23,524,722 outputs
Outputs from Drugs
#1,364
of 3,316 outputs
Outputs of similar age
#137,637
of 351,223 outputs
Outputs of similar age from Drugs
#23
of 40 outputs
Altmetric has tracked 23,524,722 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,316 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,223 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.